Eye Allergy Therapeutics Global Market Report 2025
상품코드:1810894
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
눈 알레르기 치료 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR)은 6.1%로 41억 달러에 달할 전망입니다. 예측 기간 동안 성장의 원동력은 노인 인구 증가, 생물학적 치료법의 채택 확대, 안과 연구에 대한 자금 지원 증가, 안구 알레르기 증상에 대한 인식 증가, 약물 전달 기술의 발전 등에 기인할 것으로 예측됩니다. 이 기간 동안 주요 동향으로는 개인 맞춤형 의료의 발전, 서방형 제제의 혁신, 디지털 진단 도구의 통합, 생물학적 치료의 발전, 새로운 비침습적 치료 접근법 등이 있습니다.
눈 알레르기 유병률 증가는 향후 몇 년 동안 눈 알레르기 치료 시장의 성장을 견인할 것으로 예측됩니다. 눈 알레르기는 면역체계가 알레르겐에 반응하여 눈에 염증과 염증을 유발하여 발생합니다. 눈 알레르기 증가는 환경오염의 악화가 주요 원인으로, 공기 중 알레르겐에 노출될 기회가 증가하여 더 많은 알레르기 반응을 일으킵니다. 눈 알레르기 치료는 염증을 억제하고 가려움증과 충혈을 완화하며 알레르기 반응을 예방함으로써 이러한 알레르기를 관리하고 효과적인 증상 완화를 설명합니다. 예를 들어, 2025년 5월 미국의 생물 의학 자원인 국립의학도서관은 눈 알레르기(OA)가 조사 대상의 49.3%(n=207)를 차지했고, 계절성 알레르기성 결막염(SAC)이 90.3%를 차지했으며, 주로 14세(23.4%)와 여성(58.8%)이 많았다고 보고했습니다. 따라서 눈 알레르기 유병률 증가는 눈 알레르기 치료 시장의 확대에 박차를 가하고 있습니다.
눈 알레르기 치료 시장의 주요 시장 진출기업들은 가려움증 완화 치료제를 포함한 혁신적인 제품에 집중하고 있으며, 빠른 증상 완화, 환자 편의성 향상, 시판 의약품을 통한 접근성 향상에 주력하고 있습니다. 눈 알레르기 가려움증 완화 치료는 특히 알레르기성 눈 반응으로 인한 가려움증을 대상으로 합니다. 예를 들어, 2024년 8월 인도 글렌마크제약(Glenmark Pharmaceuticals Limited)은 1일 2회 복용하는 Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1%(OTC)를 출시하였습니다. 이 제제는 눈의 가려움증, 충혈, 눈물 등의 알레르기성 결막염 증상을 빠르고 지속적으로 개선합니다. 이 OTC 제품은 셀프 케어 제품에 대한 수요 증가에 대응하고, 아이케어 시장에서 소비자의 접근성을 확대하기 위한 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계 성장 분석과 전략 분석 프레임워크
세계의 눈 알레르기 치료 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 눈 알레르기 치료 시장 : 성장률 분석
세계의 눈 알레르기 치료 시장 실적 : 규모와 성장, 2019-2024년
세계의 눈 알레르기 치료 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 눈 알레르기 치료 : 전체 시장(TAM)
제6장 시장 세분화
세계의 눈 알레르기 치료 시장 : 약제 클래스별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
항히스타민제
비만세포 안정제
이중 작용제
코르티코스테로이드
충혈 완화제
면역치료
기타
세계의 눈 알레르기 치료 시장 : 알레르기 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
계절성 알레르기성 결막염(SAC)
연중성 알레르기성 결막염(PAC)
봄철 각결막염(VKC)
아토피성 각결막염(AKC)
거대 유두 결막염
세계의 눈 알레르기 치료 시장 : 투여 경로별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
국소
경구
주사
안구
전신
세계의 눈 알레르기 치료 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원 약국
소매 약국
온라인 약국
기타 채널
세계의 눈 알레르기 치료 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원
클리닉
홈케어
약국
연구기관
세계의 눈 알레르기 치료 시장 : 항히스타민제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 눈 알레르기 치료 시장 : 비만세포 안정제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
Cromolyn Sodium
Nedocromil
Lodoxamide
Pemirolast
세계의 눈 알레르기 치료 시장 : 이중 작용제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
Olopatadine
Ketotifen Fumarate
Azelastine
Alcaftadine
세계의 눈 알레르기 치료 시장 : 코르티코스테로이드별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
Loteprednol Etabonate
Prednisolone Acetate
Dexamethasone
Fluorometholone
세계의 눈 알레르기 치료 시장 : 충혈 완화제별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
Naphazoline
Tetrahydrozoline
Oxymetazoline
Phenylephrine
세계의 눈 알레르기 치료 시장 : 면역치료별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
피하 면역치료
설하 면역치료
알레르겐 특이적 탈감작 점안제
세계의 눈 알레르기 치료 시장 : 기타별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
비스테로이드성 항염증제
생물제제
제7장 지역별/국가별 분석
세계의 눈 알레르기 치료 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 눈 알레르기 치료 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
눈 알레르기 치료 시장 : 경쟁 구도
눈 알레르기 치료 시장 : 기업 개요
Pfizer Inc.
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
AbbVie Inc.
Bayer AG
제31장 기타 주요 기업 및 혁신 기업
Novartis AG
GlaxoSmithKline plc
Teva Pharmaceutical Industries Limited
Regeneron Pharmaceuticals Inc.
Alcon Inc.
Bausch Health Companies Inc.
Sun Pharmaceutical Industries Limited
Hikma Pharmaceuticals plc
Santen Pharmaceutical Co. Ltd.
Zydus Lifesciences Limited
Stallergenes Greer Ltd.
HAL Allergy B.V.
Ocular Therapeutix Inc.
Tarsus Pharmaceuticals Inc.
Nicox S.A.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 전략
눈 알레르기 치료 시장, 2029년 : 새로운 기회를 제공하는 국가
눈 알레르기 치료 시장, 2029년 : 새로운 기회를 제공하는 부문
눈 알레르기 치료 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Eye allergy therapeutics are treatments designed to alleviate symptoms caused by allergic reactions in the eyes, such as itching, redness, swelling, and tearing. These treatments work by addressing the allergic response and may involve the use of antihistamines, mast cell stabilizers, or corticosteroids.
The primary drug categories for eye allergy treatments include antihistamines, mast cell stabilizers, dual-action agents, corticosteroids, decongestants, immunotherapy, and others. Antihistamines function by blocking histamine receptors, helping to reduce itching, redness, and swelling linked to allergies. Common types of eye allergies include seasonal allergic conjunctivitis (SAC), perennial allergic conjunctivitis (PAC), vernal keratoconjunctivitis (VKC), atopic keratoconjunctivitis (AKC), and giant papillary conjunctivitis. These medications can be administered through various routes such as topical, oral, injectable, ocular, and systemic methods. Distribution occurs via hospital pharmacies, retail pharmacies, online pharmacies, among other channels. The main end users encompass hospitals, clinics, homecare providers, pharmacies, and research institutions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The eye allergy therapeutics market research report is one of a series of new reports from The Business Research Company that provides eye allergy therapeutics market statistics, including the eye allergy therapeutics industry global market size, regional shares, competitors with the eye allergy therapeutics market share, detailed eye allergy therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the eye allergy therapeutics industry. This eye allergy therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The eye allergy therapeutics market size has grown strongly in recent years. It will grow from $3.04 billion in 2024 to $3.23 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. Several factors contributed to growth during the historic period, including the increasing prevalence of allergic conjunctivitis, greater awareness of eye allergies, higher levels of urban pollution, improved availability of advanced treatments, and enhancements in healthcare infrastructure.
The eye allergy therapeutics market size is expected to see strong growth in the next few years. It will grow to$4.10 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. Growth in the forecast period is expected to be driven by the expanding elderly population, greater adoption of biologic treatments, increased funding for ophthalmic research, heightened awareness of eye allergy symptoms, and progress in drug delivery technologies. Key trends during this time will include developments in personalized medicine, innovations in sustained-release drug formulations, the integration of digital diagnostic tools, advances in biologic therapies, and new non-invasive treatment approaches.
The increasing prevalence of eye allergies is expected to drive the growth of the eye allergy therapeutics market in the coming years. Eye allergies occur when the immune system reacts to allergens, causing inflammation and irritation in the eyes. The rise in eye allergy cases is largely attributed to worsening environmental pollution, which increases exposure to airborne allergens and triggers more allergic responses. Eye allergy therapeutics help manage these allergies by reducing inflammation, relieving itching and redness, and preventing allergic reactions to offer effective symptom relief. For example, in May 2025, the National Library of Medicine, a US-based biomedical resource, reported that ocular allergy (OA) affected 49.3% (n=207) of cases studied, with seasonal allergic conjunctivitis (SAC) making up 90.3%, primarily among 14-year-olds (23.4%) and females (58.8%). Hence, the growing incidence of eye allergies is fueling the expansion of the eye allergy therapeutics market.
Key players in the eye allergy therapeutics market are focusing on innovative products, including itch relief treatments, to provide quicker symptom relief, improve patient comfort, and increase accessibility through over-the-counter options. Eye allergy itch relief therapeutics specifically target itching caused by allergic eye reactions. For instance, in August 2024, Glenmark Pharmaceuticals Limited, an India-based company, introduced Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC), designed for twice-daily use. This formulation delivers fast and lasting relief from symptoms of allergic conjunctivitis such as itching, redness, and watery eyes. The OTC availability caters to the rising demand for self-care products and broadens consumer access within the eye care market.
In July 2023, Harrow Inc., a US-based ophthalmic pharmaceutical provider, acquired the Canadian and US ophthalmic portfolio from Santen Pharmaceutical Co. Ltd. for an undisclosed amount. This acquisition expanded Harrow's presence in North America and added established eye care brands to its portfolio. The move supports Harrow's ambition to become a leading supplier of comprehensive ophthalmic solutions. Santen Pharmaceutical Co. Ltd. is a Japan-based manufacturer specializing in eye allergy therapeutics.
Major players in the eye allergy therapeutics market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Teva Pharmaceutical Industries Limited, Regeneron Pharmaceuticals Inc., Alcon Inc., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals plc, Santen Pharmaceutical Co. Ltd., Zydus Lifesciences Limited, Stallergenes Greer Ltd., HAL Allergy B.V., Ocular Therapeutix Inc., Tarsus Pharmaceuticals Inc., Nicox S.A.
North America was the largest region in the eye allergy therapeutics market in 2024. The regions covered in eye allergy therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the eye allergy therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The eye allergy therapeutics market consists of sales of artificial tears and lubricants, natural or herbal remedies, and non-steroidal anti-inflammatory drugs. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Eye Allergy Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on eye allergy therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for eye allergy therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The eye allergy therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Drug Class: Antihistamines; Mast Cell Stabilizers; Dual-Action Agents; Corticosteroids; Decongestants; Immunotherapy; Other Drug Classes
3. Eye Allergy Therapeutics Market Trends And Strategies
4. Eye Allergy Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Eye Allergy Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Eye Allergy Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Eye Allergy Therapeutics Market Growth Rate Analysis
5.4. Global Eye Allergy Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Eye Allergy Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Eye Allergy Therapeutics Total Addressable Market (TAM)
6. Eye Allergy Therapeutics Market Segmentation
6.1. Global Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antihistamines
Mast Cell Stabillizers
Dual-Action Agents
Corticosteroids
Decongestants
Immunotherapy
Other Drug Classes
6.2. Global Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Seasonal Allergic Conjunctivitis (SAC)
Perennial Allergic Conjunctivitis (PAC)
Vernal Keratoconjunctivitis (VKC)
Atopic Keratoconjunctivitis (AKC)
Giant Papillary Conjunctivitis
6.3. Global Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Topical
Oral
Injectable
Oculae
Systemic
6.4. Global Eye Allergy Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Channels
6.5. Global Eye Allergy Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Homecare Settings
Pharmacies
Research Institutions
6.6. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Olopatadine
Ketotifen
Emedastine
Levocabastine
Bepotastine
6.7. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Mast Cell Stabilizers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cromolyn Sodium
Nedocromil
Lodoxamide
Pemirolast
6.8. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Dual-action Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Olopatadine
Ketotifen Fumarate
Azelastine
Alcaftadine
6.9. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Loteprednol Etabonate
Prednisolone Acetate
Dexamethasone
Fluorometholone
6.10. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Naphazoline
Tetrahydrozoline
Oxymetazoline
Phenylephrine
6.11. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Immunotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Allergen-specific Desensitization Drops
6.12. Global Eye Allergy Therapeutics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nonsteroidal Anti-inflammatory Drugs
Biologics
7. Eye Allergy Therapeutics Market Regional And Country Analysis
7.1. Global Eye Allergy Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Eye Allergy Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Eye Allergy Therapeutics Market
9.1. China Eye Allergy Therapeutics Market Overview
9.2. China Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Eye Allergy Therapeutics Market
10.1. India Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Eye Allergy Therapeutics Market
11.1. Japan Eye Allergy Therapeutics Market Overview
11.2. Japan Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Eye Allergy Therapeutics Market
12.1. Australia Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Eye Allergy Therapeutics Market
13.1. Indonesia Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Eye Allergy Therapeutics Market
14.1. South Korea Eye Allergy Therapeutics Market Overview
14.2. South Korea Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Eye Allergy Therapeutics Market
15.1. Western Europe Eye Allergy Therapeutics Market Overview
15.2. Western Europe Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Eye Allergy Therapeutics Market
16.1. UK Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Eye Allergy Therapeutics Market
17.1. Germany Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Eye Allergy Therapeutics Market
18.1. France Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Eye Allergy Therapeutics Market
19.1. Italy Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Eye Allergy Therapeutics Market
20.1. Spain Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Eye Allergy Therapeutics Market
21.1. Eastern Europe Eye Allergy Therapeutics Market Overview
21.2. Eastern Europe Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Eye Allergy Therapeutics Market
22.1. Russia Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Eye Allergy Therapeutics Market
23.1. North America Eye Allergy Therapeutics Market Overview
23.2. North America Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Eye Allergy Therapeutics Market
24.1. USA Eye Allergy Therapeutics Market Overview
24.2. USA Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Eye Allergy Therapeutics Market
26.1. South America Eye Allergy Therapeutics Market Overview
26.2. South America Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Eye Allergy Therapeutics Market
27.1. Brazil Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Eye Allergy Therapeutics Market
28.1. Middle East Eye Allergy Therapeutics Market Overview
28.2. Middle East Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Eye Allergy Therapeutics Market
29.1. Africa Eye Allergy Therapeutics Market Overview
29.2. Africa Eye Allergy Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Eye Allergy Therapeutics Market, Segmentation By Allergy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Eye Allergy Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Eye Allergy Therapeutics Market Competitive Landscape And Company Profiles